Showing results (1601-1610 of 3,339) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|January 6, 2021
Biochemical, histological, and neuro-physiological effects of long-term aluminum chloride exposure in ratsMansour Attiah Al-Hazmi, Sayed M Rawi, Reham Z HamzaMetabolic Brain Disease|June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinicLouise Sindzingre, Théodore Decaix, Karl Gotze, et al.Metabolic Brain Disease|June 6, 2026
Exploring DHODH inhibition with silibinin as a promising approach to treat drug resistance in epilepsyArvinder Kaur, Maninderjit Kaur, Rajesh Kumar GoelMetabolic Brain Disease|June 6, 2026
Retinal aging and diabetic retinopathy: converging metabolic pathways and shared gene expression profilesSeyedeh Mohadese Shahzadeh Fazeli, Seyedeh Parisa Chavoshi Tarzjani, Parham Daneshvar, et al.Metabolic Brain Disease|June 5, 2026
Mume Flos ameliorates MASLD-associated cognitive impairment by attenuating IL-17/NF-κB-mediated metabolic neuroinflammationShuqin Cui, Yali Wang, Qi Zhang, et al.Metabolic Brain Disease|June 4, 2026
Cannabidiol attenuates tau hyperphosphorylation and cognitive deficits in an experimental model of Alzheimer's disease and is associated with restoration of PP2A expressionSreenivasulu Sura, Saravanan Jagadeesan, Emmanuel Oshiogwe Okwuofu, et al.Metabolic Brain Disease|May 20, 2026
Neuroprotective effects of myrtenol against brain injury following isoproterenol-induced myocardial infarction in male ratsNima Rahimi Petrudi, Jalal Hassanshahi, Hossein Zeinali, et al.Metabolic Brain Disease|May 19, 2026
α-Synuclein as a molecular link between Parkinson's disease and chronic kidney disease: insights into the kidney-brain axisShavinder Kumari, Nishant Goutam, Vaishali Chaudhary, et al.Metabolic Brain Disease|May 19, 2026
Mechanistic study on the alleviating effects of cinnamaldehyde on aluminum chloride-induced cognitive impairment in zebrafish through modulating the TLR4/NF-κB signaling pathwayGuangcheng Zhong, Jiahui Shi, Yue Jiang, et al.Metabolic Brain Disease|May 19, 2026
Neuroprotective effect of sigma-1-receptor agonist 1,3-di-o-tolylguanidine in rotenone-induced model of Parkinson's disease in ratsTalha Siddiqui, Lokesh Kumar BhattPageof 334